| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20009981 | HPV | ENSG00000006283.18 | protein_coding | CACNA1G | No | No | 8913 | O43497 |
| TVIS44042288 | HTLV-1 | ENSG00000006283.18 | protein_coding | CACNA1G | No | No | 8913 | O43497 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1G |
|---|---|
| DrugBank ID | DB00593 |
| Drug Name | Ethosuximide |
| Target ID | BE0000483 |
| UniProt ID | O43497 |
| Regulation Type | inhibitor |
| PubMed IDs | 11752352; 11641441; 19005061; 11274992 |
| Citations | Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Gomora JC, Daud AN, Weiergraber M, Perez-Reyes E: Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol. 2001 Nov;60(5):1121-32.@@Wang G, Thompson SM: Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions. J Neurosci. 2008 Nov 12;28(46):11959-69. doi: 10.1523/JNEUROSCI.3296-08.2008.@@Matthews EA, Dickenson AH: Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol. 2001 Mar;415(2-3):141-9. |
| Groups | Approved |
| Direct Classification | Pyrrolidine-2-ones |
| SMILES | CCC1(C)CC(=O)NC1=O |
| Pathways | |
| PharmGKB | PA449533 |
| ChEMBL | CHEMBL696 |
